Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

It is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...

HONOLULU (HawaiiNewsNow) - The state of Hawaii has entered into a $700 million settlement agreement with pharmaceutical ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

Hawaii will receive $700 million in a landmark settlement from pharmaceutical giants Bristol Myers Squibb and Sanofi following more than a decade of litigation over the blood thinner Plavix and its ...

The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply flawed" and would not solve ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...